When assessing insomnia treatment outcomes, which statement is NOT supported by the data?

• A. All treatment groups had comparable initial insomnia levels
• B. Participants scored below the insomnia threshold immediately after treatment
• C. All groups maintained below-threshold insomnia levels at 6 months
• D. Each participant reported insomnia severity after treatment

Answer: (D)

The correct answer pertains to the specifics of data reporting rather than the actual outcomes of the insomnia treatments. When assessing data on treatment outcomes, it's essential to rely on measurable metrics, and individual reporting can introduce variability that may not accurately reflect overall treatment effects.

In contrast, the statements regarding initial insomnia levels, post-treatment scores, and long-term maintenance of insomnia levels provide more structured insights into the efficacy of different treatments. Having comparable initial levels indicates a uniform starting point for assessment. Scoring below the insomnia threshold after treatment demonstrates a significant improvement attributed to the interventions. Maintaining lower insomnia levels at a six-month follow-up indicates the potential long-term effectiveness of the treatments.

Therefore, each participant’s subjective report of insomnia severity after treatment may lack consistency and reliability and is not a quantified measure of the treatment’s effectiveness. It could also vary widely between individuals, making it less suitable as a definitive indicator of treatment outcomes compared to the other statements, which focus on more standardized measures.